Skip to main content
ConductScienceScienceDex

ScienceDex / Researcher record

Fanger, Gary

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #760
Unclaimed recordClaim profile
  • Top 5% Funded
  • Early Career

NIH Funding · FY2022

Linked Award Amount
$4.9M
Full award amounts, FY2022
Award Records
8
Records listing this PI
Award-Linked Rank
#760
By linked amount among FY2022 PIs
Earliest Year Loaded
2018
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2018$780,4502#10,414
2019$1,256,5752#6,090
2020$216,9631#19,867
2021$4,194,8265#964
2022$4,870,0448#760
2023$4,194,9485#1,009

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20182 records
  2. FY20192 records
  3. FY20201 record
  4. FY20215 records
  5. FY2022 · selected8 records
  6. FY20235 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Fanger, Gary. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2022 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2022 award records by amount

NIH award records listing Fanger, Gary as a PI. Multi-PI records show the full award amount for context.

  • 4R44CA261509-02R44Contact PI
    A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
    Rise Therapeutics, LLC
    $1M
    award amount
  • 5R44AI157031-02R44Contact PI
    A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis
    Rise Therapeutics, LLC
    $1M
    award amount
  • 5R44AI152670-03R44Contact PI
    A Novel Engineered Probiotic for the Prevention of Clostridium Difficile Infection
    Rise Therapeutics, LLC
    $973.4K
    award amount
  • 5SB1DE030833-02SB1Contact PI
    A Novel Probiotic for the Treatment of Sjogren's Syndrome
    Rise Therapeutics, LLC
    $972.1K
    award amount
  • 5R44DK117726-04R44Contact PI
    A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
    Rise Therapeutics, LLC
    $459K
    award amount
  • 1R44DK133061-01A1R44Contact PI
    A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
    Rise Therapeutics, LLC
    $360.6K
    award amount
  • 3R44DK117726-04S1R44Contact PI
    A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
    Rise Therapeutics, LLC
    $30.2K
    award amount
  • 3R44DK117726-03S1R44Contact PI
    A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
    Rise Therapeutics, LLC
    $24.9K
    award amount

Award organization

Organizations that administered FY2022 awards listing Fanger, Gary as a PI.

FY2022 award administered by Rise Therapeutics, LLC (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2018
    First NIH Award
    Rise Therapeutics, LLC
  2. 2018
    $500K Cumulative Funding
  3. 2019
    $1M Cumulative Funding
  4. 2019
    $2M Cumulative Funding
  5. 2019
    Entered Top 50% Nationally
    Ranked #6090
  6. 2021
    $5M Cumulative Funding
  7. 2021
    Entered Top 25% Nationally
    Ranked #964
  8. 2021
    Entered Top 10% Nationally
    Ranked #964
  9. 2021
    Entered Top 5% Nationally
    Ranked #964
  10. 2022
    $10M Cumulative Funding

Explore further

Find collaborators for Fanger, Gary

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →